Blair Health Raises $3 Million in Pre-Seed Funding

Blair Health, a Toronto-based healthcare company focused on providing specialist-level care in women's health without the need for referrals or waitlists, has successfully raised $3 million in a pre-seed funding round. The round was led by the Business Development Bank of Canada's Thrive Venture Fund, Accelia Capital, and Ogaei, with additional investment from the Ontario Centre of Innovation.

Expanding Access to Specialist Care

Blair Health addresses the critical gap in specialist care for women's health issues such as perimenopause, menopause, pelvic and urology, and nutrition. By enabling general healthcare providers to deliver specialist-level care, the company aims to drastically reduce waiting times for patients. Their proprietary clinical models, which are designed by specialists, ensure that generalist providers can offer accurate and timely care.

Strategic Use of Funds

The newly secured funds will be directed towards enhancing Blair Health's engineering and product development efforts. The company plans to broaden its commercial footprint within Canada and expand into the United States. Investments will also be made in clinical operations, provider networks, and infrastructure to support these expansions.

Proven Model and Future Plans

Blair Health has demonstrated success in the menopause care sector, where it has achieved 98.7% clinical accuracy. The company has expanded its model to include urology, pelvic health, and nutrition. Since its direct-to-consumer launch in May 2025, Blair Health has grown to over 2,300 users across all Canadian provinces and six U.S. states. The company also has a burgeoning employer channel, which has become a significant revenue source.

Investor Confidence

The participation of prominent investors like the Business Development Bank of Canada and the Ontario Centre of Innovation highlights confidence in Blair Health's innovative approach to healthcare. This funding round marks a significant step in the company's journey to revolutionize specialist care accessibility.